Ken Fisher's EW Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 247,420 shares of Edwards Lifesciences Corporation (EW) worth $19.24 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2020, adding 4.04 M shares. Largest reduction occurred in Q2 2025, reducing 9.78 M shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Ken Fisher
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +21,375 | New Buy | 21,375 | $61.57 |
| Q3 2019 | +6,423 | Add 30.05% | 27,798 | $73.31 |
| Q4 2019 | -4,038 | Reduce 14.53% | 23,760 | $77.78 |
| Q1 2020 | +4.04 M | Add 17004.84% | 4.06 M | $62.87 |
| Q2 2020 | +923,309 | Add 22.72% | 4.99 M | $69.11 |
| Q3 2020 | +204,982 | Add 4.11% | 5.19 M | $79.82 |
| Q4 2020 | +386,233 | Add 7.44% | 5.58 M | $91.23 |
| Q1 2021 | +244,081 | Add 4.38% | 5.82 M | $83.64 |
| Q2 2021 | +334,627 | Add 5.75% | 6.16 M | $103.57 |
| Q3 2021 | +267,356 | Add 4.34% | 6.42 M | $113.21 |
| Q4 2021 | +357,605 | Add 5.57% | 6.78 M | $129.55 |
| Q1 2022 | +320,643 | Add 4.73% | 7.1 M | $117.72 |
| Q2 2022 | +227,736 | Add 3.21% | 7.33 M | $95.09 |
| Q3 2022 | +208,057 | Add 2.84% | 7.54 M | $82.63 |
| Q4 2022 | +133,880 | Add 1.78% | 7.67 M | $74.61 |
| Q1 2023 | +146,921 | Add 1.91% | 7.82 M | $82.73 |
| Q2 2023 | +198,252 | Add 2.54% | 8.02 M | $94.33 |
| Q3 2023 | -703,324 | Reduce 8.77% | 7.31 M | $69.28 |
| Q4 2023 | -186,188 | Reduce 2.55% | 7.13 M | $76.25 |
| Q1 2024 | +498,599 | Add 6.99% | 7.63 M | $95.56 |
| Q2 2024 | +644,728 | Add 8.45% | 8.27 M | $92.37 |
| Q3 2024 | +806,705 | Add 9.75% | 9.08 M | $65.99 |
| Q4 2024 | +696,965 | Add 7.68% | 9.78 M | $74.03 |
| Q1 2025 | +325,190 | Add 3.33% | 10.1 M | $72.48 |
| Q2 2025 | -9.78 M | Reduce 96.87% | 316,392 | $78.21 |
| Q3 2025 | -68,972 | Reduce 21.80% | 247,420 | $77.77 |
Ken Fisher's Edwards Lifesciences Corporation Investment FAQs
Ken Fisher first purchased Edwards Lifesciences Corporation (EW) in Q2 2019, acquiring 21,375 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Edwards Lifesciences Corporation (EW) for 26 quarters since Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's largest addition to Edwards Lifesciences Corporation (EW) was in Q1 2020, adding 4,064,109 shares worth $255.52 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ken Fisher's firm, Fisher Asset Management, LLC, owns 247,420 shares of Edwards Lifesciences Corporation (EW), valued at approximately $19.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.01% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher's peak holding in Edwards Lifesciences Corporation (EW) was 10,100,466 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.